Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations
Iwama, E., Sakai, K., Azuma, K., Harada, T., Harada, D., Nosaki, K., Hotta, K., Ohyanagi, F., Kurata, T., Fukuhara, T., Akamatsu, H., Goto, K., Shimose, T., Kishimoto, J., Nakanishi, Y., Nishio, K., Okamoto, I.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
Occurrence of emerging contaminants in Jakarta Bay, Indonesia: pharmaceuticals and personal care products
Sudaryanto, A, Witama, R O, Nosaki, K, Tanoue, R, Suciati, F, Sachoemar, S I, Hayami, Y, Morimoto, A, Nomiyama, K, Kunisue, T
Published in IOP conference series. Earth and environmental science (01.01.2023)
Published in IOP conference series. Earth and environmental science (01.01.2023)
Get full text
Journal Article
Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042
Nosaki, K., Hosomi, Y., Saka, H., Baas, P., de Castro, G., Reck, M., Wu, Y.-L., Brahmer, J.R., Felip, E., Sawada, T., Noguchi, K., Han, S.R., Piperdi, B., Kush, D.A., Lopes, G.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study
Shimokawa, M., Nosaki, K., Seto, T., Ohashi, K., Morise, M., Fujiwara, Y., Sakakibara, J., Murakami, H., Yano, S., Satouchi, M., Matsumoto, S., Goto, K., Yoh, K.
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
P2.13-06 A Novel Clinical Scoring System (EAST score) for the Prediction of Treatment Response in Limited-Stage Small-Cell Lung Cancer
Ito, Y., Zenke, Y., Sakai, T., Shibata, Y., Izumi, H., Nosaki, K., Umemura, S., Matsumoto, S., Yoh, K., Nakamura, M., Hojo, H., Izumo, T., Goto, K.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
236TiP Large-scale prospective observational study to develop a liquid-based detection system of minimal residual disease (MRD): LC-SCRUM-MRD
Kitagawa, S., Zenke, Y., Yoh, K., Samejima, J., Kunimasa, K., Miyamoto, S., Sakakibara-Konishi, J., Toyozawa, R., Tachihara, M., Niho, S., Nosaki, K., Izumi, H., Sakai, T., Umemura, S., Sugiyama, E., Murai, K., Matsumoto, S., Tsuboi, M., Goto, K.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
MA05.10 Patient-Initiated a Phase II study (WJOG12819L) to Assess the Efficacy of Osimertinib in Patients with EGFR Mutated T790M-Negative NSCLC
Hasegawa, K., Takeda, M., Shimokawa, M., Nakamura, A., Nosaki, K., Watanabe, Y., Kato, T., Hayakawa, D., Tanaka, H., Takahashi, T., Oki, M., Tachihara, M., Fujimoto, D., Hayashi, H., Yamaguchi, K., Yamamoto, S., Iwama, E., Azuma, K., Yamamoto, N., Nakagawa, K.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
P2.10-02 Liquid Biopsy-based Umbrella Trial for Advanced NSCLC: Results of Phase 2 Plasma ALK-positive Cohort (A-Liquid)
Nakatani, Y., Nosaki, K., Sugimoto, A., Udagawa, H., Kato, T., Sakakibara-Konishi, J., Horinouchi, H., Ohashi, K., Toyozawa, R., Sakamoto, T., Morise, M., Ikeno, T., Nomura, S., Izumi, H., Matsumoto, S., Goto, K.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
997P Phase I study of brigatinib plus panitumumab in patients with advanced EGFR-mutated non-small cell lung cancer resistant to osimertinib (BEBOP): Early termination due to severe early onset pneumonitis by brigatinib
Izumi, H., Sakamoto, T., Uchibori, K., Nishino, K., Sakakibara-Konishi, J., Nomura, S., Ryohei, K., Udagawa, H., Shibata, Y., Ikeda, T., Niho, S., Sakai, T., Zenke, Y., Nosaki, K., Matsumoto, S., Yoh, K., Goto, K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
77TiP TRUST-II: A global phase II study for taletrectinib in ROS1 fusion-positive lung cancer and other solid tumors
Nagasaka, M., Sugawara, S., Choi, C-M., Okamoto, T., Yanagitani, N., Nosaki, K., Takahashi, T., Fujiwara, Y., Hayashi, H., Khoury, J., Nieva, J., Gabayan, A.E., Raez, L.E., Chen, H., Dimou, A., Pennell, N., Liu, G., Ou, S-H.I., Seto, T., Ohe, Y.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
LBA55 WJOG @Be study: A phase II study of atezolizumab (atez) with bevacizumab (bev) for non-squamous (sq) non-small cell lung cancer (NSCLC) with high PD-L1 expression
Seto, T., Nosaki, K., Shimokawa, M., Toyozawa, R., Sugawara, S., Hayashi, H., Murakami, H., Kato, T., Niho, S., Saka, H., Oki, M., Yoshioka, H., Okamoto, I., Daga, H., Azuma, K., Tanaka, H., Nishino, K., Satouchi, M., Yamamoto, N., Nakagawa, K.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
181TiP Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study
Shimokawa, M, Nosaki, K, Seto, T, Ohashi, K, Morise, M, Fujiwara, Y, Sakakibara, J, Murakami, H, Yano, S, Satouchi, M, Matsumoto, S, Goto, K, Yoh, K
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Safety and clinical activity of DS-6051b, a ROS1/NTRK inhibitor, in Japanese patients with NSCLC harboring ROS1 fusion gene
Takeda, M., Seto, T., Fujiwara, Y., Yamamoto, N., Nosaki, K., Toyozawa, R., Abe, C., Shiga, R., Nakamaru, K., Nakagawa, K.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
EP08.02-118 TRUST-II: A Global Phase II Study for Taletrectinib inROS1fusion Positive Lung Cancer and Other Solid Tumors
Misako, N., Sugawara, S., Choi, C.-M., Okamoto, T., Yanagitani, N., Nosaki, K., Takahashi, T., Fujiwara, Y., Hayashi, H., Khoury, J., Nieva, J., Gabayan, A.E., Raez, L.E., Chen, H., Dimou, A., Pennell, N., Liu, G., Ou, S.-H.I., Seto, T., Ohe, Y.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP08.02-113 Clinico-genomic Characteristics of Patients with Non-small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
Okahisa, M., Udagawa, H., Matsumoto, S., Kato, T., Oizumi, S., Furuya, N., Hayakawa, D., Toyozawa, R., Nishiyama, A., Ohashi, K., Miyamoto, S., Nishino, K., Oi, H., Sakai, T., Shibata, Y., Izumi, H., Sugiyama, E., Nosaki, K., Zenke, Y., Yoh, K., Goto, K.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
P02.03 Comparison of the Efficiency of 22G Versus 25G Needle in EBUS-TBNA for Diagnosis of Lung Cancer; A Prospective Randomized, Crossover Study
Sakai, T., Udagawa, H., Kirita, K., Nomura, S., Sugimoto, A., Itotani, R., Tamiya, Y., Izumi, H., Nosaki, K., Ikeda, T., Zenke, Y., Matsumoto, S., Yoh, K., Niho, S., Ishii, G., Goto, K.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
Safety of alectinib in non-small cell lung cancer patients with RET fusion gene (ALL-RET): Results from the dose-finding portion of a phase 1/2 study
Nosaki, K., Takeuchi, S., Takahara, S., Kawakami, T., Yoh, K., Kono, Y., Horiike, A., Seto, T., Goto, K., Yoshimura, K., Imai, Y., Murayama, T., Yano, S.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
103O_PRSafety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042
Nosaki, K, Hosomi, Y, Saka, H, Baas, P, de Castro, G, Reck, M, Wu, Y-L, Brahmer, J R, Felip, E, Sawada, T, Noguchi, K, Han, S R, Piperdi, B, Kush, D A, Lopes, G
Published in Annals of oncology (01.04.2019)
Published in Annals of oncology (01.04.2019)
Get full text
Journal Article
Real-world data on treatment patterns and survival among ALK+ NSCLC patients in Japan. Treatment patterns and survival among ALK+ NSCLC patients in Japan: Single institute experience
Seto, T., Nosaki, K., Toyozawa, R., Taguchi, K., Edagawa, M., Shimamatsu, S., Toyokawa, G., Hirai, F., Yamaguchi, M., Takeda, Y., Takenoyama, M., Ichinose, Y.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
P3.01-76 Clinical Background and Response to Chemotherapy in NSCLC Patients with MET Exon14 Skipping Mutation or High MET Gene Copy Number
Nosaki, K., Umeyama, Y., Toyozawa, R., Takamori, S., Haratake, N., Miura, N., Oba, T., Yamaguchi, M., Seto, T., Takenoyama, M., Ichinose, Y.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article